We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+16.9%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$13.2M
Cap. Flow
+$877K
Cap. Flow %
0.69%
Top 10 Hldgs %
43.94%
Holding
59
New
7
Increased
24
Reduced
19
Closed
7

Top Buys

Rank Stock Value
1
PBYI icon
Puma Biotechnology
PBYI
+$1.91M
2
TSRO
TESARO, Inc.
TSRO
+$1.8M
3
RXDX
Ignyta, Inc.
RXDX
+$1.76M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.76M
5
BKR icon
Baker Hughes
BKR
+$1.7M

Top Sells

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$2.74M
2
NXTM
NxStage Medical Inc.
NXTM
+$1.8M
3
AWI icon
Armstrong World Industries
AWI
+$1.65M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$1.58M
5
AXTA icon
Axalta
AXTA
+$1.58M

Sector Composition

Rank Sector Weight
1 Healthcare 46.68%
2 Financials 30.76%
3 Technology 5.34%
4 Consumer Discretionary 5.22%
5 Energy 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
51
DELISTED
Achillion Pharmaceuticals
ACHN
$1.52M 1.2%
337,863
-34,464
-9% -$153K
ARAV
52
DELISTED
Aravive, Inc. Common Stock
ARAV
$236K 0.19%
16,037
-287
-2% -$28.9K
AWI icon
53
Armstrong World Industries
AWI
$6.66B
– –
-35,831
Closed -$1.65M
AXTA icon
54
Axalta
AXTA
$6.92B
– –
-49,331
Closed -$1.58M
SRPT icon
55
Sarepta Therapeutics
SRPT
$1.82B
– –
-46,979
Closed -$1.58M
XNCR icon
56
Xencor
XNCR
$1.3B
– –
-70,640
Closed -$1.49M
NXTM
57
DELISTED
NxStage Medical Inc.
NXTM
– –
-71,954
Closed -$1.8M
LOXO
58
DELISTED
Loxo Oncology, Inc
LOXO
– –
-34,143
Closed -$2.74M
BHI
59
DELISTED
Baker Hughes
BHI
– –
-26,867
Closed -$1.47M
1 2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q3 2017 Portfolio in Review

As of Q3 2017, Emory University held 59 positions worth $126M, up 12% from $113M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Emory University's Q3 2017 filing shows 7 new, 24 increased, 19 reduced and 7 closed positions. Its largest new stake was Puma Biotechnology: 20,555 shares worth $2.46M. The largest sale was Loxo Oncology, Inc, an estimated $2.74M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 44% a quarter earlier, followed by Financials and Technology.

  • Emory University's largest Q3 2017 buy was Puma Biotechnology: 20,555 shares worth $2.46M.
  • Emory University added most to Ra Pharmaceuticals, Inc. Common Stock in Q3 2017, an estimated $740K increase.
  • Emory University's biggest Q3 2017 reduction was BeOne Medicines Ltd, cutting an estimated $1.36M.
  • Emory University fully exited Loxo Oncology, Inc in Q3 2017, selling an estimated $2.74M.
  • Emory University's ten largest holdings make up 44% of its $126M portfolio in Q3 2017.
  • Emory University opened 7 new positions and closed 7 in Q3 2017.
  • Emory University's portfolio value rose 12% quarter-over-quarter to $126M.

Based on Emory University's 13F filing for Q3 2017, filed 14 Nov 2017.